This is an aggregated industry headline. Read the full story at Drug Channels →
Specialty Pharmacy Accreditation: DCI’s Exclusive Analysis Reveals a Market at an Inflection Point
By Adam J. Fein, Ph.D.The Drug Channels Institute (DCI) team attended Asembia’s AXS26 Summit last week. Once again, the specialty pharmacy market delivered a classic paradox: a sprawling, fragmented landscape of participants paired with highly concentrated economics controlled by a handful of PBM-af
By Drug Channels
· May 5, 2026
· via Drug Channels
Tags
dataformat:headlineheadlineDrug Channels
The Insider - Weekly pharma intelligence
Deals, negotiations, and policy analysis. Delivered when it matters.
No sponsored content. No noise. Unsubscribe anytime.
More from Data
All Data →
DataDrug Channels ↗
By Adam J. Fein, Ph.D.Drug Channels Institute’s (DCI’s) latest analysis reveals that PBM-affiliated specialty …
Data
Despite full insurance coverage, HPV vaccination rates plateau, with racial disparities and post-pandemic decl…